Anixa Capex To Operating Cash Flow from 2010 to 2024

ANIX Stock  USD 3.30  0.01  0.30%   
Anixa Biosciences Capex To Operating Cash Flow yearly trend continues to be fairly stable with very little volatility. Capex To Operating Cash Flow will likely drop to -0.0024 in 2024. During the period from 2010 to 2024, Anixa Biosciences Capex To Operating Cash Flow regression line of annual values had r-squared of  0.05 and arithmetic mean of (0.01). View All Fundamentals
 
Capex To Operating Cash Flow  
First Reported
2010-12-31
Previous Quarter
(0)
Current Value
(0)
Quarterly Volatility
0.02278359
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Anixa Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Anixa Biosciences' main balance sheet or income statement drivers, such as Interest Expense of 216.9 K, Selling General Administrative of 4.2 M or Total Revenue of 229.4 K, as well as many indicators such as Price To Sales Ratio of 861, Dividend Yield of 0.0 or PTB Ratio of 4.39. Anixa financial statements analysis is a perfect complement when working with Anixa Biosciences Valuation or Volatility modules.
  
Check out the analysis of Anixa Biosciences Correlation against competitors.
For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.

Latest Anixa Biosciences' Capex To Operating Cash Flow Growth Pattern

Below is the plot of the Capex To Operating Cash Flow of Anixa Biosciences over the last few years. It is Anixa Biosciences' Capex To Operating Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Anixa Biosciences' overall financial position and show how it may be relating to other accounts over time.
Capex To Operating Cash Flow10 Years Trend
Pretty Stable
   Capex To Operating Cash Flow   
       Timeline  

Anixa Capex To Operating Cash Flow Regression Statistics

Arithmetic Mean(0.01)
Geometric Mean0.01
Coefficient Of Variation(249.47)
Mean Deviation0.01
Median(0)
Standard Deviation0.02
Sample Variance0.0005
Range0.099
R-Value0.22
Mean Square Error0.0005
R-Squared0.05
Significance0.44
Slope0
Total Sum of Squares0.01

Anixa Capex To Operating Cash Flow History

2024 -0.002416
2023 -0.002301
2019 -0.002557
2018 -0.037
2017 -0.008987
2016 -0.007951
2015 -0.0433

About Anixa Biosciences Financial Statements

Anixa Biosciences investors use historical fundamental indicators, such as Anixa Biosciences' Capex To Operating Cash Flow, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Anixa Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Anixa Stock Analysis

When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.